Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Cash-to-Debt : 0.26 (As of Mar. 2017)

View and export this data going back to 2001. Start your Free Trial

What is Aoxing Pharmaceutical Co Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Aoxing Pharmaceutical Co's cash to debt ratio for the quarter that ended in Mar. 2017 was 0.26.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, Aoxing Pharmaceutical Co couldn't pay off its debt using the cash in hand for the quarter that ended in Mar. 2017.

The historical rank and industry rank for Aoxing Pharmaceutical Co's Cash-to-Debt or its related term are showing as below:

AOXG's Cash-to-Debt is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.92
* Ranked among companies with meaningful Cash-to-Debt only.

Aoxing Pharmaceutical Co Cash-to-Debt Historical Data

The historical data trend for Aoxing Pharmaceutical Co's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Aoxing Pharmaceutical Co Cash-to-Debt Chart

Aoxing Pharmaceutical Co Annual Data

Trend

Jun07

Jun08

Jun09

Jun10

Jun11

Jun12

Jun13

Jun14

Jun15

Jun16

Cash-to-Debt

Get a 7-Day Free Trial

0.31

0.15

0.07

0.17

0.27

Aoxing Pharmaceutical Co Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Cash-to-Debt	Get a 7-Day Free Trial															0.23	0.27	0.28	0.28	0.26

Competitive Comparison of Aoxing Pharmaceutical Co's Cash-to-Debt

For the Drug Manufacturers - Specialty & Generic subindustry, Aoxing Pharmaceutical Co's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aoxing Pharmaceutical Co's Cash-to-Debt Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aoxing Pharmaceutical Co's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Aoxing Pharmaceutical Co's Cash-to-Debt falls into.

Aoxing Pharmaceutical Co Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Aoxing Pharmaceutical Co's Cash to Debt Ratio for the fiscal year that ended in Jun. 2016 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	6.912	/	(25.472	+	0)
	=	0.27

Aoxing Pharmaceutical Co's Cash to Debt Ratio for the quarter that ended in Mar. 2017 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	7.08	/	(27.623	+	0.1)
	=	0.26

Aoxing Pharmaceutical Co (OTCPK:AOXG) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Aoxing Pharmaceutical Co Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Aoxing Pharmaceutical Co's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aoxing Pharmaceutical Co Inc (OTCPK:AOXG) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

624 Tyvola Road, Suite 103, No. 186, Charlotte, NC, USA, 28217

Website

http://www.aoxingpharma.com

Aoxing Pharmaceutical Co Inc is a specialty pharmaceutical company. The company specializes in research, development, manufacturing, and distribution of a variety of narcotic, pain-management, and addiction treatment pharmaceutical products. Aoxing holds approximately 139 drug production certificates covering narcotic pain-management, exclusive prescription medicines, OTC and API products. It derives all its revenue from the People's Republic of China.

Executives

Wilfred Chow	officer: Chief Financial Officer	30 WEST STREET, 3B, NEW YORK NY 10004
John P Oshea	director	C/O WESTMINSTER SECURITIES CORP, 100 WALL ST, 7TH FLOOR, NEW YORK NY 10005
John Leo	director, officer: Secretary	80 WALL STREET, 5TH FLOOR, NEW YORK NY 10005

Aoxing Pharmaceutical Co (Aoxing Pharmaceutical Co) Headlines

No Headlines